OTCMKTS:FCPG First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free FCPG Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume15,858 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get First China Pharmaceutical Group alerts: Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. About First China Pharmaceutical Group Stock (OTCMKTS:FCPG)First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company’s short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers’ primary distributor, supplying more than 80% of the pharmaceutical products they require.Read More Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. FCPG Stock News HeadlinesMay 2, 2024 | msn.comPCG ship hit by China water cannon suffers over P2 million in damagesMay 2, 2024 | nytimes.comHamas and Fatah Officials, Longtime Rivals, Met in ChinaMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.April 24, 2024 | msn.comEU investigates fair access to China's medical device marketApril 16, 2024 | msn.comUS committee finds China is subsidizing American fentanyl crisisApril 16, 2024 | apnews.comHouse panel says China subsidizes fentanyl production to fuel crisis in the United StatesApril 12, 2024 | seatrade-maritime.comAstrid Maersk in China green methanol bunkering firstApril 9, 2024 | reuters.comChina graft watchdog probes official of state-owned supplier of defence gearMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 6, 2024 | yahoo.comPfizer accused of ‘bringing discredit’ on pharmaceutical industry after Covid social media postsMarch 28, 2024 | msn.comChina's Xiaomi to enter cut-throat EV market for the first timeMarch 1, 2024 | msn.comChina’s manufacturing activity contracts for 5th straight month despite policy supportFebruary 20, 2024 | morningstar.comChina Lesso Group Holdings Ltd 02128February 16, 2024 | msn.comPharmaceutical industry: public and private initiatives that are changing the gameJanuary 31, 2024 | msn.comCaixin survey shows China's factory activity expanded for a third month in January, extending divergence with official dataJanuary 4, 2024 | msn.comGlobal pharmaceutical firm Roche selects Malaysia as site for first-in-human clinical trial on experimental immunosuppressant drugDecember 29, 2023 | msn.comPharma firms urged to bring bird flu vaccines to PHDecember 29, 2023 | msn.comCell and gene therapy will be top industry trend for pharma in 2024December 4, 2023 | benzinga.comPioneering health innovations at China Int'l Supply Chain ExpoNovember 29, 2023 | msn.comChina Pharma stock soars 115% on launch update for dry eye disease deviceNovember 26, 2023 | msn.comFocus: Indian drug manufacturers benefit from Big Pharma interest beyond ChinaNovember 24, 2023 | tmcnet.com515 companies, organizations to participate in first China International Supply Chain ExpoNovember 22, 2023 | morningstar.comChina Shineway Pharmaceutical Group LtdOctober 26, 2023 | wsj.comChina Shenghai Group Ltd.October 25, 2023 | msn.comFoxconn Subsidiary Investigation: A Microcosm of China-Taiwan TensionsOctober 25, 2023 | msn.com21 mind-blowing facts about the pharmaceutical industrySeptember 18, 2023 | seekingalpha.comCSPCY CSPC Pharmaceutical Group LimitedSee More Headlines Receive FCPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First China Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolOTCMKTS:FCPG CUSIP31948N109 CIK1432254 Webwww.firstchinapharma.com Phone+86-852-21381668FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key Competitors(BVII)OTCMKTS:BVII(CBNR)OTCMKTS:CBNR(DGTC)OTCMKTS:DGTC(DTOR)OTCMKTS:DTOR(EFLO)OTCMKTS:EFLOView All Competitors FCPG Stock Analysis - Frequently Asked Questions What other stocks do shareholders of First China Pharmaceutical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other First China Pharmaceutical Group investors own include Community Bank System (CBU), Owens & Minor (OMI) and ObsEva (OBSV). How do I buy shares of First China Pharmaceutical Group? Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FCPG) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Gold Grab of the CenturyColonial Metals4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First China Pharmaceutical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.